China puts 40 strategic technologies on a new export-control track

The story

China has opened a new front in technology controls by proposing export prohibitions or licensing requirements for 40 artificial-intelligence, biomedicine and solar-manufacturing technologies. The Ministry of Commerce and Ministry of Science and Technology published the draft on October 16 and invited public comments through November 15. A temporary registration system for transfers involving the listed technologies took effect immediately, even though the catalogue revisions themselves remain proposals.

The official breakdown places 23 AI technologies, five biomedical technologies and 12 photovoltaic technologies in scope. In a separate explanation, the commerce ministry said 14 of the 40 would be prohibited from export and 26 would be restricted. The proposal covers capabilities rather than ordinary shipments alone: large models, autonomous agents, computing clusters, chip design, cell and gene therapy, small-interfering-RNA medicines, polysilicon production and advanced solar-cell manufacturing all appear within the wider plan.

AI is the centerpiece. The draft would prohibit transfers of some malicious-code generation and mutation technologies and certain agents designed for highly sensitive settings such as defense or critical information infrastructure. It would restrict other capabilities, including vulnerability discovery, large models meeting specified scale or performance thresholds, and technologies used to build major computing clusters. The Associated Press reported that one proposed model threshold is two trillion parameters, although the document does not name individual companies or products.

The policy is not a blanket ban on Chinese AI going abroad. The ministry says technology already in the public domain through open-source releases or academic publication would not be controlled. It also distinguishes a transfer of restricted model technology from access to a service: foreign use through an API, website, app or software-as-a-service product would not by itself count as exporting the underlying model technology. Overseas deployment could be controlled, while a Chinese company operating its own foreign cloud may qualify for simplified automatic licensing.

That line matters commercially. Chinese developers can continue selling model access abroad without necessarily handing over weights, training methods or the means to reproduce a system. Reuters reported that the distinction could preserve international growth for providers such as DeepSeek and Alibaba while giving Beijing more oversight when valuable capability is localized outside China. Open distribution remains possible, but firms will have to determine whether a release places controlled know-how in the public domain or constitutes a regulated transfer.

The immediate registration measure reaches beyond conventional exports. Covered cases include transferring intellectual-property ownership to a foreign party, licensing Chinese technology for overseas use, and changes that put a domestic technology owner or controller under a foreign entity. Deals already under way but not completed must also be registered. Exporters are expected to provide the parties, destination, intended use and estimated value. The requirement therefore touches mergers, corporate restructurings and licensing agreements as well as technical delivery.

Biomedicine and solar manufacturing broaden the consequences. Some ownership transfers involving proprietary cell- and gene-therapy platforms would be prohibited, while licensing arrangements that do not transfer ownership may receive automatic-license treatment. Solar provisions cover polysilicon, wafers and cell manufacturing, including critical equipment that carries the relevant know-how. These are areas in which Chinese firms hold large industrial footprints, so the eventual rules could affect how foreign factories obtain production processes, not only where finished products are sold.

Beijing describes the revision as a routine use of its foreign-trade law and says it does not target a country, region or company. It argues that the controls are intended to prevent misuse, keep AI under human control and align China with international practice. Independent coverage places the move in a sharper strategic context: the United States and allies have used export controls to limit China’s access to advanced chips and manufacturing equipment, while Chinese models and clean-energy supply chains have become increasingly competitive overseas.

INNOVOX analysis: the most important innovation-policy choice is the separation of access from replication. An API customer can use a capability; an overseas model deployment, patent assignment or transfer of manufacturing know-how can enable another organization to reproduce, modify or control it. China is designing controls around that second category. If enforced consistently, the approach could become a template for countries that want domestic technology companies to sell globally while retaining jurisdiction over their most transferable strategic assets.

What to watch next is implementation rather than the headline count. The final catalogue may change after consultation, and a restricted listing normally means licensing—not prohibition. Companies will need clarity on model-performance tests, what counts as sensitive training data, how cluster thresholds are measured and when a foreign corporate transaction changes actual control. Registration data and the first licensing decisions will reveal whether the policy mainly improves visibility for regulators or materially slows cross-border AI, biotech and solar investment.

INNOVOX analysis

The policy draws a deliberate line between transferring technical capability and selling access to a service. That distinction gives Beijing leverage over model weights, know-how, intellectual property and overseas deployment without automatically shutting Chinese AI applications out of foreign markets. It also extends technology controls beyond hardware into the organizational assets that let companies reproduce a capability elsewhere.

What to watch

Watch the final catalogue after the November 15 consultation, licensing thresholds for frontier models and computing clusters, and the treatment of joint ventures, acquisitions and overseas data centers. The first registration and licensing decisions will show whether the exemptions operate as genuine fast lanes or narrow exceptions.